## Abstract HIV infection has a significant impact on the natural progression of liver disease caused by infection with hepatitis B virus (HBV), but its role in the molecular evolution of HBV is unknown. It is difficult to study the molecular evolution of HBV longitudinally considering its genomic
Hepatitis B virus (HBV) X gene diversity and evidence of recombination in HBV/HIV co-infected persons
✍ Scribed by Christina M. Martin; Jeffrey A. Welge; Jason T. Blackard
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 592 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The high frequency of mutation during hepatitis B virus (HBV) infection has resulted in 8 genotypes (A–H) with varying effects on disease severity and treatment efficacy. However, analysis of intrapatient HBV diversity is limited, especially during HIV co‐infection. Therefore, a preliminary study was performed to analyze HBV X gene diversity in 17 HBV/HIV co‐infected individuals. Phylogenetic analysis revealed HBV genotype A in 13 individuals (76.5%) or genotype E in 1 individual (5.9%). Additionally, 3 individuals were dually infected with HBV genotypes A and G (17.6%). Overall, higher genetic distance and entropy were observed in the X region and overlapping polymerase (Pol(X)) regions when compared to the PreS, S, and overlapping polymerase (Pol(PS) and Pol(S)) regions analyzed in the same patients as part of a previous study. In addition, multiple viral variants from 2 individuals with dual HBV infection did not group with either genotype A or G by phylogenetic analysis, indicating possible recombination. SimPlot bootscan analysis confirmed recombination breakpoints within the X gene in both individuals. Recombination between HBV genotypes may represent an important evolutionary strategy that enhances overall pathogenic potential and/or alters the downstream effects of the HBV X protein. J. Med. Virol. 83:1142–1150, 2011. © 2011 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Changes in serologic status in human immunodeficiency virus (HIV)/hepatitis B virus (HBV) co‐infected individuals with either isolated anti‐HBc or resolved HBV infection have been reported, but the frequency of clinically meaningful long‐term serologic changes is not well‐defined. This
## Abstract This was an exploratory study to investigate lamivudine‐resistant hepatitis B virus (HBV) strains in selected lamivudine‐naïve HBV carriers with and without human immunodeficiency virus (HIV) co‐infection in South African patients. Thirty‐five lamivudine‐naïve HBV infected patients with
## Abstract Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) have similar transmission routes, implying that patients infected with HIV are at particular risk for HBV infection. Patients who are co‐infected with HIV and HBV progress more rapidly to end‐stage liver disease and differen
## Abstract Co‐infection with HBV and HCV seems to be associated with more severe liver disease in retrospective and cross‐sectional studies in adults, but no data are available when co‐infection is acquired in youth. The long‐term outcome of infection acquired in youth was assessed in patients co‐